Skip to main content

Fireworks on D-St ahead of Diwali; over 30 stocks rise 10-40% in a week

Stocks that rose in double digits include names like Axis Bank, Hindalco Industries, Aarti Industries, CSB Bank, State Bank of India, Bandhan Bank, IndusInd Bank, CARE Ratings, and Bajaj Finance.

Tracking positive global cues, strong inflows from foreign institutional investors, robust macro-economic data back home as well as stable Q2 numbers from India Inc. helped Nifty50 climb above 12200 levels with ease.

The S&P BSE Sensex rallied 5.75 percent while the Nifty50 rose 5.3 percent for the week ended November 6, compared to 3.3 percent rise in the S&P BSE Mid-cap index, and about 2.2 percent gain seen in the S&P BSE Smallcap index in the same period, data showed.

Small & Midcaps underperformed benchmark indices for the week ended November 6 but there are as many as 33 stocks in the S&P BSE 500 index which rose 10-40 percent in just 5 trading sessions.

Stocks that rose in double digits include names like Axis Bank, Hindalco Industries, Aarti Industries, CSB Bank, State Bank of India, Bandhan Bank, IndusInd Bank, CARE Ratings, and Bajaj Finance.



Amid the logjam in the US elections, markets across the globe rallied on liquidity in anticipation of a stimulus package from the US government. Foreign institutional investors poured more than Rs 13000 cr in the cash segment of the Indian equity markets so far in November.

“Markets made several gap-up openings in the week gone by imitating the US indices and political theatrics. It is the sheer liquidity and the hopes of a stimulus which is driving the bulls in high spirits,” Nirali Shah, Senior Research Analyst, Samco Securities told Moneycontrol.

“Therefore, irrespective of the outcome of this year’s US elections, markets are expected to continue their celebratory mood in equities and commodities across the globe,” she said.

She further added that on the macro front right from diesel consumption to PMI, from labor-intensive construction activities to GST collections all these major ground-level macro indicators are displaying strong recovery to pre-Covid levels.

Technical View:

Equity benchmarks entirely recouped last week’s losses and recorded the highest weekly close in nine months at 11264, up 5.3 percent. Sectorally, all major indices ended in green led by financials, metal, and pharma.

The weekly price action formed a sizable bull candle carrying higher high-low and resolved out of the past three weeks high 12025, as on expected line, volatility during the US election phase offered an incremental buying opportunity.

The Nifty50 s poised to hit fresh record highs by December while small & midcaps could play catch up rally in the coming week, suggest experts.“We reiterate our constructive stance of Nifty retesting life highs of 12400 by December (which was discussed in the edition of 26th October), as market panned out on expected lines. In the upcoming week, we expect a broader market to witness catch-up activity as Nifty midcap index resolved out of two months consolidation,” Dharmesh Shah, Head – Technical, ICICI Securities told Moneycontrol.

“The robust price structure makes us believe, any temporary breather from here on should be capitalised as an incremental buying opportunity. We expect a broader market to endure its catch up activity,” he said.

Shah further added that the ongoing structural improvement makes us confident to revise the support base at 11800 as it is 61.8% retracement of ongoing up move (11535-12280), at 11820.

Source - Moneycontrol.com

Disclaimer: Investment in securities market are subject to risk. Consult your financial advisor before any investment.

Comments

Post a Comment

Popular posts from this blog

Panacea Biotech shares hit 5% upper circuit after dengue vaccine completes phase I & II study

DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes, the company has said in an exchange filing. Panacea Biotech share price hit 5 percent upper circuit on the BSE on September 24 after the company completed phases I and II study of its dengue vaccine candidate DengiAIl. "Panacea Biotec Ltd. is delighted to announce the successful completion of its Phase I/II study to evaluate the safety and immunogenicity of its vaccine, DengiAll, a single-dose liveattenuated tetravalent vaccine," the company said in an exchange filing. Live-attenuated vaccines contain weakened bacteria or viruses that trigger an immune response but do not cause disease. The company said DengiAIl induced robust neutralising antibody responses against all the four dengue virus serotypes. DengiAIl has been found to be safe and well-tolerated with no serious adverse effects, the company said. After a single-dose, more than 80 percent of the participants ...
Post a Comment
Read more

Check Chemcon Speciality Chemicals IPO allotment status in four simple steps

Equity shares will get credited into the accounts of eligible investors by September 30 and the listing of equity shares will be on October 1, 2020. Chemcon Speciality Chemicals, the manufacturer for pharmaceutical and oilfields industries, is expected to announce the basis of allotment early next week. As per the schedule provided by the company, the finalisation of the basis of the allotment will be done by September 28 and the initiation of refunds or unblocking of funds from ASBA account will take place on September 29. Equity shares will get credited to the accounts of eligible investors by September 30 and the listing will be on October The IPO comprised a fresh issue of Rs 165 crore and an offer for sale of Rs 153 crore by promoters. The company will utilise fresh issue proceeds for expansion of manufacturing facility, working capital requirements, and general corporate purposes. Chemcon manufactures specialised chemicals, such as Hexamethyldisilazane (HMDS) and Chloromethyl Iso...
Post a Comment
Read more

Taking Stock | Profit-booking pulls Nifty below 14,450; Sensex drops 549 points

  All the sectoral indices ended in the red with IT and PSU bank indices falling 2 percent each. The market remained under pressure on January 15 on the back of profit-booking across sectors amid weak global cues. At close, the Sensex was down 549.49 points or 1.11% at 49,034.67, and Nifty was down 161.90 points or 1.11% at 14,433.70. "The market witnessed profit-booking and following global trends. Nifty continues to resist 14,600 and has taken a dip towards 14,360. If the market closes below 14,380 levels, we might see a correction till the levels of 14,180-14,200. Momentum indicators like RSI, MACD are indicating a small correction in the markets," said Ashis Biswas, Head of Research at CapitalVia Global Research. All the sectoral indices ended in the red with IT and PSU bank falling 2 percent each. Broader markets performed in line with the main indices with BSE Midcap and Smallcap indices falling 1 percent each. Tech Mahindra, GAIL, HCL Tech, Wipro and ONGC...
Post a Comment
Read more